Integrated genomic and transcriptional profiling identifies chromosomal loci with altered gene expression in cervical cancer

For a better understanding of the consequences of recurrent chromosomal alterations in cervical carcinomas, we integrated genome‐wide chromosomal and transcriptional profiles of 10 squamous cell carcinomas (SCCs), 5 adenocarcinomas (AdCAs) and 6 normal controls. Previous genomic profiling showed that gains at chromosome arms 1q, 3q, and 20q as well as losses at 8q, 10q, 11q, and 13q were common in cervical carcinomas. Altered regions spanned multiple megabases, and the extent to which expression of genes located there is affected remains unclear. Expression analysis of these previously chromosomally profiled carcinomas yielded 83 genes with significantly differential expression between carcinomas and normal epithelium. Application of differential gene locus mapping (DIGMAP) analysis and the array CGH expression integration tool (ACE‐it) identified hotspots within large chromosomal alterations in which gene expression was altered as well. Chromosomal gains of the long arms of chromosome 1, 3, and 20 resulted in increased expression of genes located at 1q32.1‐32.2, 3q13.32‐23, 3q26.32‐27.3, and 20q11.21‐13.33, whereas a chromosomal loss of 11q22.3‐25 was related to decreased expression of genes located in this region. Overexpression of DTX3L, PIK3R4, ATP2C1, and SLC25A36, all located at 3q21.1‐23 and identified by DIGMAP, ACE‐it or both, was confirmed in an independent validation sample set consisting of 12 SCCs and 13 normal ectocervical samples. In conclusion, integrated chromosomal and transcriptional profiling identified chromosomal hotspots at 1q, 3q, 11q, and 20q with altered gene expression within large commonly altered chromosomal regions in cervical cancer. © 2008 Wiley‐Liss, Inc.

[1]  C. Lundsteen,et al.  Comparative genomic hybridization reveals a recurrent pattern of chromosomal aberrations in severe dysplasia/carcinoma in situ of the cervix and in advanced‐stage cervical carcinoma , 1999, Genes, chromosomes & cancer.

[2]  D. Sgroi,et al.  Specific down-modulation of Notch1 signaling in cervical cancer cells is required for sustained HPV-E6/E7 expression and late steps of malignant transformation. , 2002, Genes & development.

[3]  H. Chao,et al.  Enhanced expression of alpha 2,6-sialyltransferase ST6Gal I in cervical squamous cell carcinoma. , 2003, Gynecologic Oncology.

[4]  A. Schneider,et al.  Detection of cancer‐related gene expression profiles in severe cervical neoplasia , 2004, International journal of cancer.

[5]  K. Münger,et al.  The Human DEK Proto-Oncogene Is a Senescence Inhibitor and an Upregulated Target of High-Risk Human Papillomavirus E7 , 2005, Journal of Virology.

[6]  Gordon K Smyth,et al.  Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2004, Statistical applications in genetics and molecular biology.

[7]  Yu Shyr,et al.  Coupled analysis of gene expression and chromosomal location. , 2005, Genomics.

[8]  S. Garland,et al.  Progressive genetic aberrations detected by comparative genomic hybridization in squamous cell cervical cancer , 2000, British Journal of Cancer.

[9]  Kiyoshi Yoshino,et al.  Overexpression of LAMP3/TSC403/DC-LAMP promotes metastasis in uterine cervical cancer. , 2005, Cancer research.

[10]  J. Rader,et al.  Profiling microdissected epithelium and stroma to model genomic signatures for cervical carcinogenesis accommodating for covariates. , 2007, Cancer research.

[11]  H. Moch,et al.  Prognostic value of genomic alterations in invasive cervical squamous cell carcinoma of clinical stage IB detected by comparative genomic hybridization. , 1999, Cancer research.

[12]  Erming Tian,et al.  Gene expression profiles of primary HPV16- and HPV18-infected early stage cervical cancers and normal cervical epithelium: identification of novel candidate molecular markers for cervical cancer diagnosis and therapy. , 2005, Virology.

[13]  S. Artavanis-Tsakonas,et al.  Alterations in Notch signaling in neoplastic lesions of the human cervix. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[14]  S. Petersen,et al.  Human papilloma virus status and chromosomal imbalances in primary cervical carcinomas and tumour cell lines , 2000, European journal of cancer.

[15]  Chen-Yang Shen,et al.  Monoclonality and surface lesion‐specific microsatellite alterations in premalignant and malignant neoplasia of uterine cervix: a local field effect of genomic instability and clonal evolution , 1999, Genes, chromosomes & cancer.

[16]  H. Tsuda,et al.  Clinical significance of immunocytochemistry for PIK3CA as a carcinogenesis-related marker on liquid-based cytology in cervical intraepithelial neoplasia. , 2006, Oncology reports.

[17]  J. Rader,et al.  Identification of chromosomal alterations important in the development of cervical intraepithelial neoplasia and invasive carcinoma using alignment of DNA microarray data. , 2006, Gynecologic oncology.

[18]  M. Sherman,et al.  Detection of genomic amplification of the human telomerase gene (TERC) in cytologic specimens as a genetic test for the diagnosis of cervical dysplasia. , 2003, The American journal of pathology.

[19]  Chen-Yang Shen,et al.  PIK3CA as an oncogene in cervical cancer , 2000, Oncogene.

[20]  Paola Pisani,et al.  Estimates of the world‐wide prevalence of cancer for 25 sites in the adult population , 2002, International journal of cancer.

[21]  J. Nesland,et al.  PROGNOSTIC VALUE OF EPHA2 AND EPHRINA-1 IN SQUAMOUS CELL CERVICAL CARCINOMA , 2004, International Journal of Gynecologic Cancer.

[22]  P. Snijders,et al.  GP5+/6+ PCR followed by Reverse Line Blot Analysis Enables Rapid and High-Throughput Identification of Human Papillomavirus Genotypes , 2002, Journal of Clinical Microbiology.

[23]  Yu Shyr,et al.  Gene Expression Differences Associated with Human Papillomavirus Status in Head and Neck Squamous Cell Carcinoma , 2006, Clinical Cancer Research.

[24]  C J L M Meijer,et al.  Increased gene copy numbers at chromosome 20q are frequent in both squamous cell carcinomas and adenocarcinomas of the cervix , 2006, The Journal of pathology.

[25]  K. Basso,et al.  Gene dosage alterations revealed by cDNA microarray analysis in cervical cancer: Identification of candidate amplified and overexpressed genes , 2007, Genes, chromosomes & cancer.

[26]  M. Emi,et al.  Down‐regulation of members of glycolipid‐enriched membrane raft gene family, MAL and BENE, in cervical squamous cell cancers , 2004, The journal of obstetrics and gynaecology research.

[27]  C. R. Leemans,et al.  Using tissue adjacent to carcinoma as a normal control: an obvious but questionable practice , 2004, The Journal of pathology.

[28]  Hiroshi Suzuki,et al.  ATP2C1 is specifically localized in the basal layer of normal epidermis and its depletion triggers keratinocyte differentiation. , 2006, Journal of dermatological science.

[29]  E. Schröck,et al.  Advanced‐stage cervical carcinomas are defined by a recurrent pattern of chromosomal aberrations revealing high genetic instability and a consistent gain of chromosome arm 3q , 1997, Genes, chromosomes & cancer.

[30]  Tzu-Hao Wang,et al.  Molecular characterization of adenocarcinoma and squamous carcinoma of the uterine cervix using microarray analysis of gene expression , 2006, International journal of cancer.

[31]  I. Petersen,et al.  Microarray comparative genomic hybridization detection of chromosomal imbalances in uterine cervix carcinoma , 2005, BMC Cancer.

[32]  Li Zhao,et al.  Oncogenic PI3K deregulates transcription and translation , 2005, Nature Reviews Cancer.

[33]  M. Sakamoto,et al.  Comparative genomic hybridization detects genetic alterations during early stages of cervical cancer progression , 2002, Genes, chromosomes & cancer.

[34]  F. Natt,et al.  Amino acids mediate mTOR/raptor signaling through activation of class 3 phosphatidylinositol 3OH-kinase. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[35]  C. Lundsteen,et al.  Comparative genomic hybridization reveals non-random chromosomal aberrations in early preinvasive cervical lesions. , 2001, Cancer genetics and cytogenetics.

[36]  Harald zur Hausen,et al.  Papillomaviruses Causing Cancer: Evasion From Host-Cell Control in Early Events in Carcinogenesis , 2000 .

[37]  E. Calhoun,et al.  Comparison of gene expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix. , 2004, Gynecologic oncology.

[38]  David I. Smith,et al.  Genome‐wide gene expression profiling of cervical cancer in Hong Kong women by oligonucleotide microarray , 2006, International journal of cancer.

[39]  J. Shaughnessy,et al.  Gene expression profiles of primary HPV 16-and HPV 18-infected early stage cervical cancers and normal cervical epithelium : identification of novel candidate molecular markers for cervical cancer diagnosis and therapy , 2004 .

[40]  Kerstin Heselmeyer-Haddad,et al.  Tumorigenesis and Neoplastic Progression Genomic Amplification of the Human Telomerase Gene ( TERC ) in Pap Smears Predicts the Development of Cervical Cancer , 2005 .

[41]  W. E. Orr,et al.  Comparing the use of Affymetrix to spotted oligonucleotide microarrays using two retinal pigment epithelium cell lines. , 2003, Molecular vision.

[42]  David Yang,et al.  Identification of cervical cancer markers by cDNA and tissue microarrays. , 2003, Cancer research.

[43]  A. Sparks,et al.  The Genomic Landscapes of Human Breast and Colorectal Cancers , 2007, Science.

[44]  C. R. Leemans,et al.  Expression profiling and prediction of distant metastases in head and neck squamous cell carcinoma , 2006, Journal of Clinical Pathology.

[45]  Ricardo C T Aguiar,et al.  The BAL-binding Protein BBAP and Related Deltex Family Members Exhibit Ubiquitin-Protein Isopeptide Ligase Activity* , 2003, Journal of Biological Chemistry.

[46]  K. Hui,et al.  Identification and characterization of genes involved in the carcinogenesis of human squamous cell cervical carcinoma , 2002, International journal of cancer.

[47]  Y. Fu.  Pathology of the Uterine Cervix, Vagina and Vulva , 2002 .

[48]  P. Rao,et al.  Chromosomal amplifications, 3q gain and deletions of 2q33-q37 are the frequent genetic changes in cervical carcinoma , 2004, BMC Cancer.

[49]  E. Schröck,et al.  Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[50]  A. Molven,et al.  Molecular analysis of the PI3K‐AKT pathway in uterine cervical neoplasia: Frequent PIK3CA amplification and AKT phosphorylation , 2006, International journal of cancer.

[51]  K. Raj,et al.  The role of Notch in tumorigenesis: oncogene or tumour suppressor? , 2003, Nature Reviews Cancer.

[52]  M. Stanley,et al.  Genomic imbalances in 70 snap-frozen cervical squamous intraepithelial lesions: associations with lesion grade, state of the HPV16 E2 gene and clinical outcome , 2004, British Journal of Cancer.

[53]  M. A. van de Wiel,et al.  Profiling of apoptosis genes allows for clinical stratification of primary nodal diffuse large B‐cell lymphomas , 2007, British journal of haematology.

[54]  Jeroen Beliën,et al.  ACE-it: a tool for genome-wide integration of gene dosage and RNA expression data , 2006, Bioinform..

[55]  C. Meijer,et al.  HPV-mediated transformation of the anogenital tract. , 2005, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[56]  C. R. Leemans,et al.  A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. , 2003, Cancer research.

[57]  Chi-Hung Lin,et al.  Frequent gain of copy number on the long arm of chromosome 3 in human cervical adenocarcinoma. , 2001, Cancer genetics and cytogenetics.

[58]  José A García,et al.  Overexpression of cathepsin f, matrix metalloproteinases 11 and 12 in cervical cancer , 2005, BMC Cancer.

[59]  H. Chao,et al.  Enhanced expression of α 2,6-sialyltransferase ST6Gal I in cervical squamous cell carcinoma , 2003 .

[60]  N. Tanaka,et al.  Molecular definition of a small amplification domain within 3q26 in tumors of cervix, ovary, and lung. , 2000, Cancer genetics and cytogenetics.